These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 15569297)

  • 1. Re: Status dystonicus and Hallervorden-Spatz disease.
    Flett PJ
    J Paediatr Child Health; 2004 Dec; 40(12):721. PubMed ID: 15569297
    [No Abstract]   [Full Text] [Related]  

  • 2. Status dystonicus and Hallervorden-Spatz disease: treatment with intrathecal baclofen and pallidotomy.
    Kyriagis M; Grattan-Smith P; Scheinberg A; Teo C; Nakaji N; Waugh M
    J Paediatr Child Health; 2004; 40(5-6):322-5. PubMed ID: 15151592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pantothenate - kinase associated neurodegeneration.
    Parmar A; Khare S; Srivastav V
    J Assoc Physicians India; 2012 Apr; 60():74-6. PubMed ID: 23029753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin for treatment of jaw opening dystonia in Hallervorden-Spatz syndrome.
    Dressler D; Wittstock M; Benecke R
    Eur Neurol; 2001; 45(4):287-8. PubMed ID: 11385272
    [No Abstract]   [Full Text] [Related]  

  • 5. Intrathecal morphine therapy in the management of status dystonicus in neurodegeneration brain iron accumulation type 1.
    Lopez WO; Kluge Schroeder H; Santana Neville I; Jacobsen Teixeira M; Costa Barbosa D; Assumpçao de Mônaco B; Talamoni Fonoff E
    Pediatr Neurosurg; 2015; 50(2):94-8. PubMed ID: 25896138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Status dystonicus: predictors of outcome and progression patterns of underlying disease.
    Fasano A; Ricciardi L; Bentivoglio AR; Canavese C; Zorzi G; Petrovic I; Kresojevic N; Kostić VS; Svetel M; Kovacs N; Balas I; Roubertie A; Mishra D; Mariotti P; Temudo T; Nardocci N
    Mov Disord; 2012 May; 27(6):783-8. PubMed ID: 22488948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical Hallervorden-Spatz disease with preserved cognition and obtrusive obsessions and compulsions.
    Nicholas AP; Earnst KS; Marson DC
    Mov Disord; 2005 Jul; 20(7):880-6. PubMed ID: 15834858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The eye-of-the-tiger sign is not a reliable disease marker for Hallervorden-Spatz syndrome.
    Baumeister FA; Auer DP; Hörtnagel K; Freisinger P; Meitinger T
    Neuropediatrics; 2005 Jun; 36(3):221-2. PubMed ID: 15944911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of classic pantothenate kinase-associated neurodegeneration with deferiprone and intrathecal baclofen.
    Pratini NR; Sweeters N; Vichinsky E; Neufeld JA
    Am J Phys Med Rehabil; 2013 Aug; 92(8):728-33. PubMed ID: 23370589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tourettism, hemiballism and juvenile Parkinsonism: expanding the clinical spectrum of the neurodegeneration associated to pantothenate kinase deficiency (Hallervorden Spatz syndrome)].
    Carod-Artal FJ; Vargas AP; Marinho PB; Fernandes-Silva TV; Portugal D
    Rev Neurol; 2004 Feb 16-29; 38(4):327-31. PubMed ID: 14997456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hallervorden-Spatz disease and botulinum toxin].
    Riol Diego M; Narbona García J
    An Esp Pediatr; 1997 Oct; 47(4):443-4. PubMed ID: 9499321
    [No Abstract]   [Full Text] [Related]  

  • 12. Hallervorden Spatz disease.
    Sabat SB; Deshmukh MP
    J Assoc Physicians India; 2006 Aug; 54():629. PubMed ID: 16941794
    [No Abstract]   [Full Text] [Related]  

  • 13. Hallervorden-Spatz disease in a psychiatric setting.
    Morphy MA; Feldman JA; Kilburn G
    J Clin Psychiatry; 1989 Feb; 50(2):66-8. PubMed ID: 2914882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rapid evolution of presenile dementia in a case of Hallervorden-Spatz disease].
    Rizzuto N; Radermecker J
    Acta Neurol (Napoli); 1967; 22(2):281-90. PubMed ID: 5304557
    [No Abstract]   [Full Text] [Related]  

  • 15. Hallervoredn-Spatz disease.
    ; ; ;
    J Coll Physicians Surg Pak; 2006 Aug; 16(8):545-7. PubMed ID: 16899188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The superior mesenteric artery syndrome: an unusual complication in a patient with the Hallervorden-Spatz syndrome.
    Massa G; Casaer P; Marchal G; Eggermont E
    Acta Gastroenterol Belg; 1989; 52(5-6):436-40. PubMed ID: 2486013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hallervorden-Spatz disease: presentation of a new case].
    Pedrola D; Pineda M; Fernández Alvarez E
    Rev Neurol; 1995; 23(119):51-3. PubMed ID: 8548643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mandibular fracture in a patient with pantothenate kinase-associated neurodegeneration (Hallervorden-Spatz syndrome)].
    Piña MA; Sáez VP
    Rev Esp Anestesiol Reanim; 2012 Jan; 59(1):55-6. PubMed ID: 22429637
    [No Abstract]   [Full Text] [Related]  

  • 19. Status dystonicus in pantothenate kinase-associated neurodegeneration due to internal pulse generator depletion: Case study and literature review.
    Li H; Zhang C; Pan Y; Sun B; Li D; Wu Y
    J Neurol Sci; 2019 May; 400():44-46. PubMed ID: 30903858
    [No Abstract]   [Full Text] [Related]  

  • 20. Hallervorden Spatz disease: MR imaging.
    Shah J; Patkar D; Patankar T; Krishnan A; Prasad S; Limdi J
    J Postgrad Med; 1999; 45(4):114-7. PubMed ID: 10734349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.